Regeneron Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good morning, everybody. I'm Matthew Harrison, one of the biotech analysts, and pleased to start the session off today with Regeneron. Quickly before we get started, I just need to read a disclosure statement. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you're a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley representatives.
So pleased to have Bob Landry, the CFO; Marion McCourt, who runs Commercial; and Justin Holko, who heads IR at Regeneron. I know Bob and Marion, you wanted to make some opening statements. So I'll let you do that and then we can jump into Q&A.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |